Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BURU compared with LIMN: revenue, margins and what each company keeps, and the suppliers and customers both name
BURU
Nuburu, Inc.
Change
Mkt cap
Revenue
Revenue
LIMN
Liminatus Pharma, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
BURU
Nuburu, Inc.
vs
LIMN
Liminatus Pharma, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only BURU
5
—
Undisclosed customer
unlisted
customer
—
Orbit S.r.l
unlisted
supplier
—
Tcei
unlisted
supplier
—
Tekne
unlisted
supplier
1 more · BURU chain
›
Shared
0
No disclosed counterparties: LIMN.
Only LIMN
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
BURU
Nuburu, Inc.
Change
0.20
▼
−17.14%
· post 0.19
Mkt cap
$965,285
Revenue
$524,927
Q2 FY26
LIMN
Liminatus Pharma, Inc.
Change
2.63
▼
−5.88%
· post 2.68
Closed
Nov 5 '26
Mkt cap
$2.7M
Revenue
—
vs
Compare
Closed
Nov 5 '26
BURU
Nuburu, Inc.
vs
LIMN
Liminatus Pharma, Inc.
0.20
▼
−17.14%
post 0.19
Price
2.63
▼
−5.88%
post 2.68
$965,285
Mkt cap
$2.7M
Q2 FY26
$524,927
Revenue
—
Change
Change
BURU
0.20
▼
−17.14%
vs
LIMN
2.63
▼
−5.88%
Closed
Nov 5 '26